![Thomas Cavanagh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Thomas Cavanagh
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Oxular Ltd.
![]() Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom.
8
| Holding Company | Biotechnology | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Thomas Cavanagh tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Veryan Medical Ltd.
![]() Veryan Medical Ltd. BiotechnologyHealth Technology Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Touchstone Innovations Investment Management Ltd.
![]() Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Investment Managers | Chief Investment Officer Private Equity Analyst | |
University of Oxford | College/University | Undergraduate Degree Doctorate Degree | |
Molten Ventures (Private Equity)
![]() Molten Ventures (Private Equity) Investment ManagersFinance Molten Ventures (Private Equity) (Molten Ventures) is a venture capital firm subsidiary of Molten Ventures Plc founded in 1998 by Simon Christopher Cook and Stuart Malcolm Chapman. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
Ieso Digital Health Ltd.
![]() Ieso Digital Health Ltd. Commercial Printing/FormsCommercial Services Ieso Digital Health Ltd. provides Internet enabled mental health services to health providers, private individuals and businesses. The firm engages in delivering cognitive behavioral therapy. It offers anxiety, bereavement, child and family, depression, drug and alcohol misuse, eating disorder, managing anger, managing pain, obsessive compulsive disorder, panic, phobia, post traumatic stress, relationship, sexual difficulty, sports psychology, stress management, and terminal illness therapy services. The company was founded by Barnaby Perks, Sue Wright and Nadine Field in 2000 and is headquartered in Cambridge, the United Kingdom. | Commercial Printing/Forms | Chief Executive Officer Director/Board Member | |
University of Cambridge | College/University | Undergraduate Degree Undergraduate Degree | |
IMAGO BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
NeoMed S.à.r.l. | Investment Managers | Private Equity Investor | |
TopiVert Ltd.
![]() TopiVert Ltd. BiotechnologyHealth Technology TopiVert Ltd. develops topical treatments for inflammatory diseases of the eye and gut. Its application is used in the treatment of asthma, chronic obstructive pulmonary disease, and cystic fibrosis and other inflammatory diseases of the lungs. The company was founded by Eric Charles Meldrum in 2011 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
OrbiMed Advisors Private Equity
![]() OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
Orbimed Advisors Private Equity/UK/ | Investment Managers | Private Equity Investor | |
WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
THE MONKS INVESTMENT TRUST PLC | Investment Trusts/Mutual Funds | Director/Board Member | |
Anjarium Biosciences AG
![]() Anjarium Biosciences AG BiotechnologyHealth Technology Anjarium Biosciences AG is a Swiss company that focuses on creating a new class of non-viral gene therapies to tackle genetic diseases throughout a patient's lifetime. The company is based in Schlieren, Switzerland. The company's versatile platform leverages breakthrough science and expertise at the interface of genetic medicine, synthetic biology, and nanoparticle engineering to generate a pipeline of advanced gene therapies with unique competitive advantages over current viral-vector based gene therapies. Anjarium's investors include leading international and strategic investors such as Abingworth, Gimv, Omega Funds, Pfizer Ventures, and Surveyor Capital. The company was founded by Joël de Beer, and Stephen Yoo has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
Invest Europe
![]() Invest Europe Investment ManagersFinance Invest Europe is a Belgian company that operates as a private equity, venture capital and infrastructure investment company. The company is based in Brussels, Belgium. | Investment Managers | Director/Board Member | |
IFM Continua, Inc.
![]() IFM Continua, Inc. BiotechnologyHealth Technology IFM Continua, Inc. engages in the provision of biotechnology services. The company is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Attenua, Inc.
![]() Attenua, Inc. Pharmaceuticals: MajorHealth Technology Attenua, Inc. engages in the provision of biopharmaceutical services. The company was founded by Jing Liang and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member | |
IFM Cinque, Inc.
![]() IFM Cinque, Inc. Miscellaneous Commercial ServicesCommercial Services IFM Cinque, Inc. is a biotechnology company. The company is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
IFM Quattro, Inc.
![]() IFM Quattro, Inc. Miscellaneous Commercial ServicesCommercial Services IFM Quattro, Inc. is a biotechnology company. The company is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Topivert Pharma Ltd.
![]() Topivert Pharma Ltd. Pharmaceuticals: MajorHealth Technology Topivert Pharma Ltd. is a British pharmaceutical company founded in 2011. The private company develops non-systemic medicines for the treatment of chronic inflammatory diseases of the gastrointestinal. | Pharmaceuticals: Major | Director/Board Member | |
Oxular Acquisitions Ltd. | Director/Board Member | ||
Omega Fund Management LLC
![]() Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US. | Investment Managers | Private Equity Investor | |
Neomed Management (Jersey) Ltd.
![]() Neomed Management (Jersey) Ltd. Investment ManagersFinance Neomed Management (Jersey) Ltd. is an investment firm invests in innovative healthcare and life science companies. The company is headquartered in St. Helier, the United Kingdom. | Investment Managers | Corporate Officer/Principal | |
SPRUCE BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
LGC Ltd.
![]() LGC Ltd. Miscellaneous Commercial ServicesCommercial Services LGC Ltd. engages in the provision of scientific tool and solutions. It offers genomic analysis tools, drug development solutions, national laboratory, and health research program management. The company was founded in 1842 and is headquartered in Middlesex, the United Kingdom. | Miscellaneous Commercial Services | General Counsel | |
Inivata Ltd.
![]() Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Packaged Software | Corporate Officer/Principal | |
Complement Therapeutics Ltd.
![]() Complement Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Complement Therapeutics Ltd. develops medicines that target the complement system. The British company was founded by Richard Unwin, Simon J. Clark, and Paul Bishop. The CEO is Rafiq Hasan. | Pharmaceuticals: Major | Director/Board Member | |
RWTH Aachen University | College/University | Doctorate Degree | |
Forbion Capital Partners Germany GmbH | Investment Managers | Private Equity Investor | |
Vedere Bio II, Inc.
![]() Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | Miscellaneous Commercial Services | Chief Operating Officer | |
Boston University | College/University | Graduate Degree | |
University of Pennsylvania | College/University | Undergraduate Degree | |
Virtual Software Systems, Inc.
![]() Virtual Software Systems, Inc. Packaged SoftwareTechnology Services Virtual Software Systems, Inc. develops a software platform to provide protection for data and applications running in public, private, and hybrid clouds on bare metal or embedded systems. The company was founded in 2014 and is headquartered in Burlington, MA. | Packaged Software | Director/Board Member | |
The Royal Veterinary College | College/University | Corporate Officer/Principal | |
ApcinteX Ltd.
![]() ApcinteX Ltd. BiotechnologyHealth Technology ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Duke University
![]() Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Corporate Officer/Principal | |
LGC Group Holdings Ltd.
![]() LGC Group Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services LGC Group Holdings, Ltd. provides pharmaceutical research and laboratory services. It offers chemical analysis and diagnostic services for the public and private sectors. The company was founded in 1996 and is headquartered in Teddington, the United Kingdom. | Miscellaneous Commercial Services | General Counsel | |
Puridify Ltd.
![]() Puridify Ltd. Miscellaneous Commercial ServicesCommercial Services Puridify Ltd. develops bioprocessing technologies. It develops a platform purification technology that will improve processing opportunities and reduce costs. The company was founded by Oliver Hardick, Iwan Thomas Roberts and Thomas Edward Haywood in 2013 and is headquartered in Stevenage, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
City of London College | College/University | Graduate Degree | |
ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Human Resources Officer | |
CONSORT MEDICAL PLC | Pharmaceuticals: Major | General Counsel | |
VERNALIS | Pharmaceuticals: Major | General Counsel | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member | |
Cephalon, Inc.
![]() Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | General Counsel |
Statistiche
Distribuzione geografica
Regno Unito | 25 |
Stati Uniti | 17 |
Svizzera | 4 |
Germania | 3 |
Irlanda | 2 |
Settori
Health Technology | 21 |
Finance | 11 |
Consumer Services | 10 |
Commercial Services | 8 |
Technology Services | 3 |
Posizioni
Director/Board Member | 59 |
Private Equity Investor | 12 |
Corporate Officer/Principal | 11 |
General Counsel | 8 |
Corporate Secretary | 7 |
Contatti più connessi
Insiders | |
---|---|
Nigel Pitchford | 29 |
Dina Chaya | 23 |
David Fellows | 16 |
Inga Deakin | 12 |
John Edward Ilett | 11 |
Ronald K. Yamamoto | 9 |
Mark Gaffney | 5 |
Dmitrij Hristodorov | 5 |
- Borsa valori
- Insiders
- Thomas Cavanagh
- Connessioni Società